-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

619.O1.6 619. Acute Myeloid Leukemias: Disease Burden and Minimal Residual Disease in Prognosis and Treatment: Measurable Residual Disease in AML in 2024 and Beyond

Symposia: Acute Myeloid Leukemias: Disease Burden and Minimal Residual Disease in Prognosis and Treatment Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Clinical trials, Adult, Translational Research, Clinical Practice (Health Services and Quality), Clinical Research, Diseases, Real-world evidence, Treatment Considerations, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Measurable Residual Disease , Pathogenesis, Molecular testing
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Moderators:
Tobias Herold, MD, University Hospital, LMU Munich and Laura W Dillon, PhD, National Heart, Lung, and Blood Institute
Disclosures:
Herold: Jazz Pharmaceuticals: Honoraria; Servier Deutschland: Honoraria.
2:00 PM

Sun Loo, MBBS1,2, Harry Iland, MBBS, FRACP, FRCPA3, Ing Soo Tiong, FRACP, FRCPA, MPhil4,5,6, David Westerman, MBBS, FRCPA, FRACP4,5, Jad Othman, FRACP, FRCPA, MBBS7, Paula Marlton8*, Chong Chyn Chua, MBBS, FRACP, FRCPA2,9, Duncan Purtill, MBBS, FRACP, FRCPA10*, Hannah Rose11*, Shaun Fleming, MBBS, FRACP, FRACPA12*, Deepak Singhal, MBBS, MD, FRACP, FRCPA13*, Anoop K Enjeti, MBBS, FRCPA, MD, MRCP14,15, William S. Stevenson, MBBS, PhD7, Teng Fong Ng, BSc, MBBS, MRCP, FRACP, FRCPA16,17*, McCulloch Derek3*, Lachlin Vaughan, MBBS, PhD18*, Robin Gasiorowski, MA, FRACP, FRCPA, MBBS19, Adam Ivey, PhD20*, Amanda Souza21*, Revati Pattani, PhD21*, Natasha S. Anstee, PhD2,22*, Rachel Koldej, PhD23,24, David S. Ritchie, MBChB PhD23,24,25, Sanam Loghavi, MD26, Naval Daver, MD27, Courtney D. DiNardo, MD, MSc27, Andrew W. Roberts, MBBS, PhD1,22,28, Carolyn S. Grove, MBBS, FRACP, FRCPA, PhD29,30, John Reynolds, BSc, MSc, PhD31* and Andrew H Wei, MBBS, PhD, FRACP, FRCPA2,22,25

1Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
2The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
3Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, Australia
4Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia
5Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
6The Royal Melbourne Hospital, Melbourne, Australia
7Royal North Shore Hospital, Redfern, NSW, Australia
8Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia
9Monash Hospital and Monash University, Rosanna, VIC, Australia
10Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
11Department of Haematology, University Hospital Geelong, Geelong, Australia
12Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, VIC, Australia
13Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
14Department of Haematology, Calvary Mater Hospital, Waratah, NSW, Australia
15School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia
16Gold Coast University Hospital, Queensland, Australia
17Griffith University, QLD, Australia
18Westmead Hospital, Sydney, Australia
19Concord Hospital, University of Sydney, Concord, NSW, Australia
20Human Molecular Pathology, The Alfred Hospital, Melbourne, Australia
21Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
22Department of Medical Biology, The University of Melbourne, Melbourne, Australia
23Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia
24ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Parkville, VIC, Australia
25Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
26Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
27Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
28The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
29Sir Charles Gairdner Hospital, Nedlands, Australia
30School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia
31Department of Malignant Haematology, Transplantation and Cellular Therapy Services, Alfred Health, Melbourne, Australia

2:15 PM

Meagan Jacoby, MD1, David H Spencer, MD, PhD2, Geoffrey L. Uy, MD3, Feng Gao4*, Tasha Burton5*, Sharon E Heath5*, Feiyu Du6*, Shelly O'Laughlin6*, Robert Fulton7*, Zeina A. Al-Mansour, MD8, Christopher R. Cogle, MD9*, Eric J Huselton, MD10*, John F. DiPersio, MD, PhD11, Peter Westervelt, MD11, Mark A. Schroeder, MD12, Armin Ghobadi, MD12, Iskra Pusic, MD11, Keith Stockerl-Goldstein, MD12, Brad S. Kahl, MD13, Amanda F. Cashen, MD14, Matt Christopher, MD15, Nathan Singh, MD14, Ravi Vij, MD, MBA14, Zachary D. Crees, MD11, Ryan B. Day, MD, PhD16, Todd A Fehniger17, Karolyn Oetjen, MD6, Dilan A. Patel, MD18*, Miriam Y Kim, MD14, Michael Slade, MD, MS11, Daniel C. Link, MD3, Matthew J. Walter, MD19, Camille N. Abboud, MD14, Ramzi Abboud20 and Timothy J Ley, MD21

1Washington University-School of Medicine, St. Louis, MO
2Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St Louis, MO
3Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
4Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, MO
5Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
6Washington University School of Medicine, St. Louis
7McDonnell Genome Institute, St Louis, MO
8Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL
9University of Florida, Gainesville, FL
10James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
11Division of Oncology, Washington University School of Medicine, Saint Louis, MO
12Division of Oncology, Washington University School of Medicine, St. Louis, MO
13Department of Medicine, Washington University School of Medicine, St. Louis, MO
14Washington University School of Medicine, Saint Louis, MO
15Washington University School of Medicine, St. Louis,, MO
16Department of Internal Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University in St. Louis School of Medicine, Saint Louis, MO
17Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
18Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
19Washington University In St. Louis, Saint Louis, MO
20Washington University School of Medicine, St. Louis, MO
21Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

2:30 PM

Carlos Jimenez-Vicente1,2*, Aina Cardus3*, Guillermo Ramil López, MD4,5*, Guadalupe Onate, MD, PhD6*, Iago Arribas, MD7*, Sara Garcia-Avila, MD8*, Lucia Gomez-Perez, MD9*, Daniel Esteban, MD10*, Antonella Sturla11*, Francesca Guijarro, MD12,13*, Mònica López-Guerra14,15*, Sandra Castaño-Díez, MD14,16*, Alexandra Martínez-Roca12,17*, Albert Cortés-Bullich, MD12,18*, Amanda Isabel Perez, MD19*, Ines Zugasti17*, Inés Monge-Escartin20*, Jorge Sierra, MD21, Susana Vives, MD22,23*, Helena Pomares24*, Montserrat Arnan, MD, PhD25*, Josep Nomdedeu26*, Ana Garrido, MD4*, Marta Pratcorona, MD, PhD4,5*, Marina Díaz-Beyá, MD, PhD14,16* and Jordi Esteve, MD, PhD14,27

1Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
2Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS),, Barcelona, Spain
3Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
4Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
5IIB-Sant Pau, Sant Pau Biomedical Research Institute, Barcelona, Spain
6Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
7Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona., L'Hospitalet De Llobregat, Barcelona., Spain
8Hospital del Mar, Barcelona, Spain
9Department of Hematology, Hospital del Mar, Barcelona, Spain
10Hospital Universitari Germans Trias i Pujol - Institut Català d'Oncologia, Badalona, Spain
11Servei d’Hematologia, Institut Català d’Oncologia, Hospital Duran i Reynals, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet, Spain
12Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
13Hematopathology Unit, Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain
14Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
15Hematopathology Section, Pathology Department, Hospital Clínic Barcelona, Barcelona, Spain
16Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
17Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain
18Hospital Clínic de Barcelona, Barcelona, Spain
19Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
20Pharmacy Department, Hospital Clinic De Barcelona, Barcelona, ESP
21Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
22Hematology Department, Institut Catala d'Oncologia - Hospital Germans Trias i Pujol, Badalona, Spain
23Hospital Germans Trias i Pujol, Badalona, ESP
24Clinical Hematology Department, ICO-Hospitalet, Hospital Durán i Reynals. IDIBELL, Barcelona., Barcelona, Spain
25Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain
26Hospital de la Santa Creu i Sant Pau, Barcelona, AL, ESP
27Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain

2:45 PM

Adriana Plesa1*, Stéphanie Mathis, PharmD2*, Florent Dumezy, PharmD3*, Anne-Catherine Lhoumeau, PharmD, PhD4*, Veronique Saada, PharmD5*, Isabelle Arnoux, PharmD6*, Jennifer Osman, PharmD7*, Nicolas Chapuis, MD, PhD8*, Franck Geneviève, MD9*, Mikael Roussel, MD, PhD10*, Delphine Manzoni, PharmD11*, Anne Roggy, PharmD12*, Remi Letestu, MD13*, Veronique Harrivel, MD14*, Elsa Bera, MD15*, Jean Feuillard, MD, PhD16*, Hélène Lapillonne, MD, PhD17*, Richard Veyrat-Masson, MD18*, Tatiana Raskovalova, MD19*, Bouchra Badaoui, PharmD20*, Valerie Bardet, PharmD, PhD21*, Caroline Mayeur-Rousse, MD22*, Francois Vergez, DVM, PhD23*, Jean Philippe Vial, MD24*, Valerie Goncalves Monteiro, PharmD25*, Frédéric Feger, PharmD26*, Dominique Penther, MD27*, Isabelle Luquet, MD28*, Eric Delabesse, MD, PhD29*, Nicolas Duployez, PharmD, PhD30*, Karine Celli-Lebras, RN31*, Mathilde Hunault, MD, PhD32*, Raphael Itzykson33, Arnaud Pigneux, MD, PhD34*, Christian Récher, MD, PhD35, Hervé Dombret, MD, PhD36,37, Claude Preudhomme, PharmD, PhD38* and Christophe Roumier, PharmD39*

1Laboratory of Hematology and Flow cytometry, Coordinator of the AML French MRDflow LSC Network, Lyon University Hospital, CHU-HCL, Lyon Sud, Pierre Benite, France
2Laboratory of Hematology and Flow cytometry, Saint Louis Hospital, APHP, Paris, France
3Laboratory of Hematology and Flow cytometry, CHU Lille, Lille, France
4Laboratory of Hematology and Flow cytometry, Cancer Biology department, Institut Paoli-Calmettes, Marseille, France
5Laboratory of Hematology and Flow cytometry, Gustave Roussy Institute, VILLEJUIF, France
6Laboratory of Hematology and Flow cytometry, La Timone University Hospital, AP-HM, Marseille, France
7Laboratory of Hematology and Flow cytometry, CH Versailles Hospital, Le Chesnay, France
8Laboratory of Hematology and Flow cytometry, Cochin Hospital, AP-HP Paris, Paris, France
9Laboratory of Hematology and Flow cytometry, CHU Angers, Angers, France
10Laboratory of Hematology and Flow cytometry, CHU Rennes, Rennes, France
11Laboratory of Hematology and Flow cytometry, CHU Lyon Sud, HCL, Pierre Bénite-Lyon Sud, France
12Laboratory of Hematology and Flow cytometry, CHU Besançon, Besançon, France
13Laboratory of Hematology and Flow cytometry, CHU Avicenne Hospital, Bobigny, France
14Laboratory of Hematology and Flow cytometry, CHU Amiens, Amiens, France
15Laboratory of Hematology and Flow cytometry, CHU Rouen, Rouen, France
16Laboratory of Hematology and Flow cytometry, CHU Limoges, Limoges, France
17Laboratory of Hematology and Flow cytometry, Trousseau Hospital, Paris, France
18Laboratory of Hematology and Flow cytometry, CHU Clermont Ferrand, Clermont Ferrand, France
19Laboratory of Hematology and Flow cytometry, CHU Grenoble, Grenoble, France
20Laboratory of Hematology and Flow cytometry, Henri Mondor University Hospital, AP-HP, Créteil, France
21Laboratory of Hematology and Flow cytometry, Ambroise Pare Hospital, Boulogne, France
22Laboratory of Hematology and Flow cytometry, CHU Strasbourg, Strasbourg, France
23Laboratory of Hematology and Flow cytometry, CHU Toulouse, Toulouse, France
24Laboratory of Hematology and Flow cytometry, CHU Bordeaux, Pessac Cedex, France
25Laboratory of Hematology and Flow cytometry, CHU Reims, Reims, France
26Laboratory of Hematology and Flow cytometry, Saint Antoine Hospital, AP-HP, Paris, France
27Department of Genetic Oncology, Henri Becquerel Center, CHU Rouen, Rouen, France
28Laboratory of Hematology, CHU Toulouse, Toulouse, France
29Laboratory of Hematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France
30Laboratory of Hematology-Molecular Biology, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France
31ALFA Coordination, Hôpital Saint-Louis, Paris, France
32Department of Clinical Hematology, CHU Angers, Angers, France
33Hematology Department, Saint Louis University Hospital, AP-HP, Paris, France
34Department of Clinical Hematology, Haut-Lévèque Hospital, CHU Bordeaux, Pessac, France
35Department of Clinical Hematology, CHU Toulouse, Toulouse, France
36Department of Clinical Hematology, Saint Louis University Hospital, Université Paris Cité-AP-HP, Paris, France
37EA-3518, Saint Louis Research Institute, Université Paris Cité, Paris, France
38Laboratory of Hematology-Molecular Biology, CHU Lille, Lille, France
39Laboratory of Hematology and Flow cytometry, Coordinator of the AML French MRDflow LSC Network, CHU Lille, Lille, France

3:00 PM

Loic Vasseur1,2*, Matthieu Duchmann, MD, PhD3,4*, Nicolas Duployez, PharmD, PhD5,6*, Emmanuel Raffoux, MD7*, Celine Berthon, MD, PhD6,8*, Mael Heiblig, MD, PhD9*, Alexis Genthon, MD10*, Thorsten Braun, MD, PhD11, Mathieu Leclerc, MD, PhD12*, Delphine Lebon, MD13*, Sylvain Chantepie, MD14*, Jean-Baptiste Micol, MD15, Juliette Lambert, MD, PhD16*, Christian Recher, MD, PhD17*, Marie-Lorraine Chrétien, MD18*, Thomas Cluzeau, MD, PhD19, Julien Vaidie, MD20*, Jean-Valère Malfuson, MD21*, Madalina Uzunov, MD22*, Arnaud Pigneux, MD, PhD23*, Pierre Peterlin24*, Sihem Tarfi, PharmD25*, Pierre Hirsch, MD, PhD26*, Dominique Penther, MD27*, Eric Jourdan, MD, PhD28*, Karine Celli-Lebras, RN29*, Claude Preudhomme, PharmD, PhD5,6*, Hervé Dombret, MD, PhD7,30, Jérôme Lambert, MD, PhD2,31*, Nicolas Boissel, MD, PhD1,30 and Raphael Itzykson3,7

1Adolescent and Young Adult Hematology Unit, Saint Louis University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
2ECSTRRA team, Centre for Research in Epidemiology and Statistics, INSERM U1153, Université Paris Cité, Paris, France
3Unité 944/7212-GenCellDi, Saint-Louis Research Institute, INSERM, CNRS, Université Paris Cité, Paris, France
4Hematology Laboratory, Saint Louis University Hospital, AP-HP, Paris, France
5Laboratory of Hematology-Molecular Biology, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France
6ONCOLILLE - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, IRCL, CNRS-UMR9020, Inserm-U1277, Lille, France
7Hematology Department, Saint Louis University Hospital, AP-HP, Paris, France
8Hematology Department, CHU Lille, Lille, France
9Hematology Department, CHU de Lyon, Pierre-Bénite, France
10Hematology Department, Saint Antoine University Hospital, AP-HP, Paris, France
11Hematology Department, Avicenne University Hospital, AP-HP, Bobigny, France
12Hematology Department, Henri Mondor University Hospital, AP-HP, Créteil, France
13Hematology Department, CHU Amiens, Amiens, France
14Basse-Normandie Institute of Hematology, CHU de Caen, Caen, France
15Hematology Department, Gustave Roussy Institute, Villejuif, France
16Clinical Hematology Department, Versailles Hospital, Le Chesnay-Rocquencourt, France
17Hematology Department, Cancer University Institute of Toulouse Oncopole, Toulouse, France
18Hematology Department, CHU Dijon, Dijon, France
19Department for Clinical Hematology, Nice University Hospital, Nice, France
20Hematology Department, Dupuytren University Hospital, Limoges, France
21Clinical Hematology Department, Percy Army Training Hospital, Clamart, France
22Clinical Hematology Department, Pitié-Salpétrière University Hospital, AP-HP, Paris, France
23Department of Clinical Hematology, Haut-Lévèque Hospital, CHU Bordeaux, Pessac, France
24Hematology Department, Hôtel-Dieu University Hospital, NANTES CEDEX 1, France
25Hematology and Immunology Department, Henri Mondor University Hospital, AP-HP, Créteil, France
26Hematology Laboratory, Saint Antoine University Hospital, AP-HP, Paris, France
27Department of Genetic Oncology, Henri Becquerel Center, CHU Rouen, Rouen, France
28Clinical Hematology Departement, CHU de Nimes, Nimes, France
29ALFA Group Coordination, Saint Louis Research Institute, Paris, France
30EA-3518, Saint Louis Research Institute, Université Paris Cité, Paris, France
31Biostatistics and Medical Information Department, Saint Louis University Hospital, AP-HP, Paris, France

3:15 PM

Evangelia Antoniou, MD1,2, Lina Marie Hoffmeister1,2*, Nils Von Neuhoff, PhD1,2*, Dirk Reinhardt, MD1,2, Markus Schneider, PhD1,2* and Stephanie Sendker, MD2*

1University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
2AML-BFM Study Group, Essen, Germany

*signifies non-member of ASH